Pancreatic Cancer Clinical Trials in California

Showing 61-63 of 63 trials

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

NCT00326911

Eligible patients with metastatic pancreatic cancer will be treated with dual agent monoclonal antibody consisting of cetuximab and bevacizumab alone or in combination with gemcitabine

Metastatic Pancreatic Cancer

Eli Lilly and Company61 participantsStarted May 2006

Jonesboro, Arkansas, United States • San Francisco, California, United States • Stamford, Connecticut, United States +13 more locations

COMPLETEDPhase 1254 miles

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

NCT00465725

Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.

Bladder CancerBreast CancerColorectal Cancer+6 more

Poniard Pharmaceuticals18 participantsStarted Apr 2007

Atlanta, Georgia, United States • Las Vegas, Nevada, United States • Tacoma, Washington, United States

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Pancreatic Cancer Trials in Other Cities

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Other Conditions in California